These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 27832839)
1. Microparticles and Nanoparticles Delivered in Intravenous Saline and in an Intravenous Solution of a Therapeutic Antibody Product. Pardeshi NN; Qi W; Dahl K; Caplan L; Carpenter JF J Pharm Sci; 2017 Feb; 106(2):511-520. PubMed ID: 27832839 [TBL] [Abstract][Full Text] [Related]
2. Compatibility, physical stability, and characterization of an IgG4 monoclonal antibody after dilution into different intravenous administration bags. Kumru OS; Liu J; Ji JA; Cheng W; Wang YJ; Wang T; Joshi SB; Middaugh CR; Volkin DB J Pharm Sci; 2012 Oct; 101(10):3636-50. PubMed ID: 22733600 [TBL] [Abstract][Full Text] [Related]
4. No Touching! Abrasion of Adsorbed Protein Is the Root Cause of Subvisible Particle Formation During Stirring. Sediq AS; van Duijvenvoorde RB; Jiskoot W; Nejadnik MR J Pharm Sci; 2016 Feb; 105(2):519-529. PubMed ID: 26869415 [TBL] [Abstract][Full Text] [Related]
5. Synergistic Effect of Cavitation and Agitation on Protein Aggregation. Torisu T; Maruno T; Hamaji Y; Ohkubo T; Uchiyama S J Pharm Sci; 2017 Feb; 106(2):521-529. PubMed ID: 27887723 [TBL] [Abstract][Full Text] [Related]
6. Off-label use of plastic syringes with silicone oil for intravenous infusion bags of antibodies. Kim NA; Hada S; Kim DJ; Choi DH; Jeong SH Eur J Pharm Biopharm; 2021 Sep; 166():205-215. PubMed ID: 34237379 [TBL] [Abstract][Full Text] [Related]
8. Effects of Transportation of IV Bags Containing Protein Formulations Via Hospital Pneumatic Tube System: Particle Characterization by Multiple Methods. Linkuvienė V; Ross EL; Crawford L; Weiser SE; Man D; Kay S; Kolhe P; Carpenter JF J Pharm Sci; 2022 Apr; 111(4):1024-1039. PubMed ID: 35093336 [TBL] [Abstract][Full Text] [Related]
9. Protein Adsorption to In-Line Filters of Intravenous Administration Sets. Besheer A J Pharm Sci; 2017 Oct; 106(10):2959-2965. PubMed ID: 28559043 [TBL] [Abstract][Full Text] [Related]
10. Defining the right diluent for intravenous infusion of therapeutic antibodies. Luo S; McSweeney KM; Wang T; Bacot SM; Feldman GM; Zhang B MAbs; 2020; 12(1):1685814. PubMed ID: 31774346 [TBL] [Abstract][Full Text] [Related]
11. Impact of NaCl on Monoclonal Antibody Aggregation Induced by Agitation. Hong JKY; Liu W; Zheng K PDA J Pharm Sci Technol; 2024 Aug; 78(4):465-474. PubMed ID: 39179400 [TBL] [Abstract][Full Text] [Related]
12. Processing Impact on Monoclonal Antibody Drug Products: Protein Subvisible Particulate Formation Induced by Grinding Stress. Gikanga B; Eisner DR; Ovadia R; Day ES; Stauch OB; Maa YF PDA J Pharm Sci Technol; 2017; 71(3):172-188. PubMed ID: 27789805 [TBL] [Abstract][Full Text] [Related]
13. Subvisible particle counting provides a sensitive method of detecting and quantifying aggregation of monoclonal antibody caused by freeze-thawing: insights into the roles of particles in the protein aggregation pathway. Barnard JG; Singh S; Randolph TW; Carpenter JF J Pharm Sci; 2011 Feb; 100(2):492-503. PubMed ID: 20803602 [TBL] [Abstract][Full Text] [Related]
14. An Approach to Mitigate Particle Formation on the Dilution of a Monoclonal Antibody Drug Product in an IV Administration Fluid. Zheng S; Adams M; Mantri RV J Pharm Sci; 2016 Mar; 105(3):1349-50. PubMed ID: 26886343 [TBL] [Abstract][Full Text] [Related]
15. Protein Nanoparticles Promote Microparticle Formation in Intravenous Immunoglobulin Solutions During Freeze-Thawing and Agitation Stresses. Pardeshi NN; Zhou C; Randolph TW; Carpenter JF J Pharm Sci; 2018 Jul; 107(7):1852-1857. PubMed ID: 29601840 [TBL] [Abstract][Full Text] [Related]
16. IgG particle formation during filling pump operation: a case study of heterogeneous nucleation on stainless steel nanoparticles. Tyagi AK; Randolph TW; Dong A; Maloney KM; Hitscherich C; Carpenter JF J Pharm Sci; 2009 Jan; 98(1):94-104. PubMed ID: 18454482 [TBL] [Abstract][Full Text] [Related]
17. Evaluating the Role of the Air-Solution Interface on the Mechanism of Subvisible Particle Formation Caused by Mechanical Agitation for an IgG1 mAb. Ghazvini S; Kalonia C; Volkin DB; Dhar P J Pharm Sci; 2016 May; 105(5):1643-1656. PubMed ID: 27025981 [TBL] [Abstract][Full Text] [Related]
18. Usefulness of the final filter of the IV infusion set in intravenous administration of drugs--contamination of injection preparations by insoluble microparticles and its causes. Kuramoto K; Shoji T; Nakagawa Y Yakugaku Zasshi; 2006 Apr; 126(4):289-95. PubMed ID: 16596019 [TBL] [Abstract][Full Text] [Related]
19. Characterization of subvisible particle formation during the filling pump operation of a monoclonal antibody solution. Nayak A; Colandene J; Bradford V; Perkins M J Pharm Sci; 2011 Oct; 100(10):4198-204. PubMed ID: 21698601 [TBL] [Abstract][Full Text] [Related]
20. Suppression of Aggregation of Therapeutic Monoclonal Antibodies during Storage by Removal of Aggregation Precursors Using a Specific Adsorbent of Non-Native IgG Conformers. Senga Y; Honda S Bioconjug Chem; 2018 Oct; 29(10):3250-3261. PubMed ID: 30264991 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]